Table 3.
Selection of relevant small molecules measured in health monitoring. The current state-of-art testing method is mentioned, as well as whether an aptamer against the analyte is available or not.
| Analyte | Indication | Current Testing Method | Aptamer Available? (Y/N) | Year | Ref. |
|---|---|---|---|---|---|
| Aldosterone | Hypertension | Radioimmunometric | N | - | - |
| Bilirubin | Hyperbilirubinemia | Colorimetric | N | - | - |
| Cortisol | Hypercortisolism/Hypocortisolism | Radioimmunometric | Y | 2017 | [71] |
| Creatinine | Kidney health | Fluorometric/Colorimetric | N | - | - |
| Estradiol | Hormonal illnesses in women | ELISA | Y | 2007 | [72] |
| Progesterone | Wide range of indications | Radioimmunometric | Y | 2015 | [73] |
| Testosterone | Wide range of indications | Radioimmunometric | Y | 2017 | [74] |
| Uric acid | Hyperuricemia/Hypouricemia | Fluorometric/Colorimetric | N | - | - |
| 25(OH)D3 | Vitamin D deficiency | HPLC | Y | 2017 | [33] |